Pembrolizumab with etoposide and a platinum-based compound for untreated extensive-stage small-cell lung cancer [ID1509]

  • Discontinued
  • GID-TA10413

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators